Ilan Oren

Ilan Oren currently works at Dexcel Pharma Technologies Ltd., as Co-Chief Executive Officer from 2019, Dexcel Ltd., as Co - CEO, Roivant Sciences Ltd., as Independent Chairman from 2023, Roivant Sciences, Inc., as Director, Clexio Biosciences Ltd., as Director from 2018, Kriya Therapeutics, Inc., as Director from 2020, and 8400 - The Health Network, as Director from 2019.
Mr. Oren also formerly worked at Cynapsus Therapeutics, Inc., as Independent Director from 2014 to 2016, Sio Gene Therapies, Inc., as Director from 2018 to 2020, Sio Gene Therapies, Inc., as Non-Executive Director from 2015 to 2017, and Montes Archimedes Acquisition Corp., as Independent Director.
Mr. Oren received his undergraduate degree from Harvard College.